Major depressive disorder (MDD) or clinical depression, is a mental disorder marked by symptoms such as persistent depressed mood, loss of interest, appetite changes, feeling of worthlessness, and others that hinder one’s daily life.
Hightower Clinical will soon begin a clinical trial for adults diagnosed with Major Depressive Disorder (MDD). The study will evaluate the safety and effectiveness of an investigational drug used along with a regular antidepressant, compared to placebo. Participants may also have the option to continue in an open-label extension phase.
Major Depressive Disorder
Upcoming
Oklahoma
MDD is a mental health condition marked by persistent feelings of sadness, hopelessness, and loss of interest in daily activities.
Adjunctive treatment means the study drug will be used in addition to your current antidepressant, not as a replacement.
An open-label extension is a follow-up study where all participants may receive the investigational drug, and both doctors and patients know what treatment is being given.
